HAIAU
HAIAU
Healthcare AI Acquisition Corp.Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q2-2025 | $0 | $0 ▼ | $-542.06K ▼ | 0% | $-0.1 ▼ | $0 ▲ |
| Q1-2025 | $0 | $75.83K ▼ | $-74.12K ▼ | 0% | $-0.01 ▼ | $-75.83K ▲ |
| Q4-2024 | $0 | $99.49K ▼ | $385.56K ▲ | 0% | $0.07 ▲ | $-99.49K ▲ |
| Q3-2024 | $0 | $413.04K ▲ | $-7.66K ▼ | 0% | $-0 ▼ | $-413.04K ▼ |
| Q2-2024 | $0 | $70.75K | $145.66K | 0% | $0.02 | $-70.75K |
What's going well?
The only minor positive is a slight reduction in share count, which avoids shareholder dilution. No new debt or interest expenses were reported.
What's concerning?
The company still has zero revenue and losses are growing fast, from -$74,119 last quarter to -$542,059 now. With no sales and rising losses, the business looks unsustainable in its current state.
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q2-2025 | $212 | $2.86M ▼ | $3.16M ▲ | $-2.17M ▼ |
| Q1-2025 | $212 | $5.75M ▲ | $2.56M ▲ | $3.19M ▼ |
| Q4-2024 | $212 | $5.66M ▼ | $2.39M ▲ | $3.26M ▼ |
| Q3-2024 | $212 | $6.85M ▲ | $1.73M ▲ | $5.11M ▼ |
| Q2-2024 | $212 | $6.79M | $1.67M | $5.12M |
What's financially strong about this company?
The only bright spot is that all debt has been paid off this quarter, so there is no immediate risk from lenders.
What are the financial risks or weaknesses?
The company has almost no cash, negative equity, and owes much more than it owns. Current assets can't cover short-term bills, and the asset base is unclear and illiquid.
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q4-2024 | $385.56K ▲ | $-122.7K ▲ | $0 | $122.7K ▼ | $0 | $-122.7K ▲ |
| Q3-2024 | $-7.66K ▼ | $-323.43K ▼ | $0 | $323.43K ▲ | $0 | $-323.43K ▼ |
| Q2-2024 | $145.66K ▲ | $0 | $0 | $0 | $0 | $0 |
| Q1-2024 | $-466.72K ▼ | $0 ▼ | $0 | $0 | $0 | $0 ▼ |
| Q4-2023 | $303.78K | $411.84K | $0 | $0 | $0 | $411.84K |
What's strong about this company's cash flow?
Cash burn is shrinking compared to last quarter, so losses are getting smaller. No shareholder dilution or capital spending means no extra cash outflows.
What are the cash flow concerns?
The company is still losing real cash every quarter and has almost no cash on hand. It depends entirely on borrowing to keep going, which is risky.
5-Year Trend Analysis
A comprehensive look at Healthcare AI Acquisition Corp.'s financial evolution and strategic trajectory over the past five years.
Key positives include the fact that HAIAU carries a simple asset structure with little in the way of complex intangibles, and it has already navigated much of the SPAC process toward securing an operating target. The planned merger with Leading Group provides a path from being a non-operating shell to owning a licensed digital insurance brokerage in a large, growing market. Leading Group’s positioning as a technology-enabled channel partner to insurers, its regulatory licensing, and its network of carrier relationships all represent meaningful strategic assets if they can be maintained and scaled.
Major risks stem from the current financial fragility and the uncertainties around the business combination. HAIAU’s historical financials show no revenue, persistent negative cash flow, shrinking assets, higher relative leverage, and tight liquidity—all of which leave limited room for delays or setbacks. The merger itself may face execution, regulatory, and market risks, and even if completed, investors will be exposed to the regulatory, competitive, and macroeconomic environment in China’s insurance and technology sectors. On top of this, the lack of detailed disclosure on the target’s technology, profitability, and unit economics adds informational uncertainty.
Looking ahead, HAIAU’s future profile will be determined far more by the success of the Leading Group transaction than by its historical SPAC-era numbers. In the near term, financial statements are likely to remain shaped by deal costs, financing flows, and balance-sheet restructuring. Over the medium term, the key questions will be whether the combined company can convert its digital platform and partnerships into steady revenue growth, positive cash generation, and a defensible competitive position in China’s digital insurance market. The range of possible outcomes is wide, with both meaningful opportunity and significant risk, and the eventual trajectory will depend heavily on execution quality, regulatory conditions, and market competition rather than on HAIAU’s past financial track record.
About Healthcare AI Acquisition Corp.
Healthcare AI Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q2-2025 | $0 | $0 ▼ | $-542.06K ▼ | 0% | $-0.1 ▼ | $0 ▲ |
| Q1-2025 | $0 | $75.83K ▼ | $-74.12K ▼ | 0% | $-0.01 ▼ | $-75.83K ▲ |
| Q4-2024 | $0 | $99.49K ▼ | $385.56K ▲ | 0% | $0.07 ▲ | $-99.49K ▲ |
| Q3-2024 | $0 | $413.04K ▲ | $-7.66K ▼ | 0% | $-0 ▼ | $-413.04K ▼ |
| Q2-2024 | $0 | $70.75K | $145.66K | 0% | $0.02 | $-70.75K |
What's going well?
The only minor positive is a slight reduction in share count, which avoids shareholder dilution. No new debt or interest expenses were reported.
What's concerning?
The company still has zero revenue and losses are growing fast, from -$74,119 last quarter to -$542,059 now. With no sales and rising losses, the business looks unsustainable in its current state.
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q2-2025 | $212 | $2.86M ▼ | $3.16M ▲ | $-2.17M ▼ |
| Q1-2025 | $212 | $5.75M ▲ | $2.56M ▲ | $3.19M ▼ |
| Q4-2024 | $212 | $5.66M ▼ | $2.39M ▲ | $3.26M ▼ |
| Q3-2024 | $212 | $6.85M ▲ | $1.73M ▲ | $5.11M ▼ |
| Q2-2024 | $212 | $6.79M | $1.67M | $5.12M |
What's financially strong about this company?
The only bright spot is that all debt has been paid off this quarter, so there is no immediate risk from lenders.
What are the financial risks or weaknesses?
The company has almost no cash, negative equity, and owes much more than it owns. Current assets can't cover short-term bills, and the asset base is unclear and illiquid.
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q4-2024 | $385.56K ▲ | $-122.7K ▲ | $0 | $122.7K ▼ | $0 | $-122.7K ▲ |
| Q3-2024 | $-7.66K ▼ | $-323.43K ▼ | $0 | $323.43K ▲ | $0 | $-323.43K ▼ |
| Q2-2024 | $145.66K ▲ | $0 | $0 | $0 | $0 | $0 |
| Q1-2024 | $-466.72K ▼ | $0 ▼ | $0 | $0 | $0 | $0 ▼ |
| Q4-2023 | $303.78K | $411.84K | $0 | $0 | $0 | $411.84K |
What's strong about this company's cash flow?
Cash burn is shrinking compared to last quarter, so losses are getting smaller. No shareholder dilution or capital spending means no extra cash outflows.
What are the cash flow concerns?
The company is still losing real cash every quarter and has almost no cash on hand. It depends entirely on borrowing to keep going, which is risky.
5-Year Trend Analysis
A comprehensive look at Healthcare AI Acquisition Corp.'s financial evolution and strategic trajectory over the past five years.
Key positives include the fact that HAIAU carries a simple asset structure with little in the way of complex intangibles, and it has already navigated much of the SPAC process toward securing an operating target. The planned merger with Leading Group provides a path from being a non-operating shell to owning a licensed digital insurance brokerage in a large, growing market. Leading Group’s positioning as a technology-enabled channel partner to insurers, its regulatory licensing, and its network of carrier relationships all represent meaningful strategic assets if they can be maintained and scaled.
Major risks stem from the current financial fragility and the uncertainties around the business combination. HAIAU’s historical financials show no revenue, persistent negative cash flow, shrinking assets, higher relative leverage, and tight liquidity—all of which leave limited room for delays or setbacks. The merger itself may face execution, regulatory, and market risks, and even if completed, investors will be exposed to the regulatory, competitive, and macroeconomic environment in China’s insurance and technology sectors. On top of this, the lack of detailed disclosure on the target’s technology, profitability, and unit economics adds informational uncertainty.
Looking ahead, HAIAU’s future profile will be determined far more by the success of the Leading Group transaction than by its historical SPAC-era numbers. In the near term, financial statements are likely to remain shaped by deal costs, financing flows, and balance-sheet restructuring. Over the medium term, the key questions will be whether the combined company can convert its digital platform and partnerships into steady revenue growth, positive cash generation, and a defensible competitive position in China’s digital insurance market. The range of possible outcomes is wide, with both meaningful opportunity and significant risk, and the eventual trajectory will depend heavily on execution quality, regulatory conditions, and market competition rather than on HAIAU’s past financial track record.

CEO
Jiande Chen

